Cargando…

In-silico engineering of RNA nanoplatforms to promote the diabetic wound healing

One of the most notable required features of wound healing is the enhancement of angiogenesis, which aids in the acceleration of regeneration. Poor angiogenesis during diabetic wound healing is linked to a shortage of pro-angiogenic or an increase in anti-angiogenic factors. As a result, a potential...

Descripción completa

Detalles Bibliográficos
Autores principales: Beheshtizadeh, Nima, Salimi, Alireza, Golmohammadi, Mahsa, Ansari, Javad Mohajer, Azami, Mahmoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251717/
https://www.ncbi.nlm.nih.gov/pubmed/37291669
http://dx.doi.org/10.1186/s13065-023-00969-4
_version_ 1785056002078408704
author Beheshtizadeh, Nima
Salimi, Alireza
Golmohammadi, Mahsa
Ansari, Javad Mohajer
Azami, Mahmoud
author_facet Beheshtizadeh, Nima
Salimi, Alireza
Golmohammadi, Mahsa
Ansari, Javad Mohajer
Azami, Mahmoud
author_sort Beheshtizadeh, Nima
collection PubMed
description One of the most notable required features of wound healing is the enhancement of angiogenesis, which aids in the acceleration of regeneration. Poor angiogenesis during diabetic wound healing is linked to a shortage of pro-angiogenic or an increase in anti-angiogenic factors. As a result, a potential treatment method is to increase angiogenesis promoters and decrease suppressors. Incorporating microRNAs (miRNAs) and small interfering RNAs (siRNAs), two forms of quite small RNA molecules, is one way to make use of RNA interference. Several different types of antagomirs and siRNAs are now in the works to counteract the negative effects of miRNAs. The purpose of this research is to locate novel antagonists for miRNAs and siRNAs that target multiple genes to promote angiogenesis and wound healing in diabetic ulcers. In this context, we used gene ontology analysis by exploring across several datasets. Following data analysis, it was processed using a systems biology approach. The feasibility of incorporating the proposed siRNAs and miRNA antagomirs into polymeric bioresponsive nanocarriers for wound delivery was further investigated by means of a molecular dynamics (MD) simulation study. Among the three nanocarriers tested (Poly (lactic-co-glycolic acid) (PLGA), Polyethylenimine (PEI), and Chitosan (CTS), MD simulations show that the integration of PLGA/hsa-mir-422a is the most stable (total energy = -1202.62 KJ/mol, Gyration radius = 2.154 nm, and solvent-accessible surface area = 408.416 nm(2)). With values of -25.437 KJ/mol, 0.047 nm for the Gyration radius, and 204.563 nm(2) for the SASA, the integration of the second siRNA/ Chitosan took the last place. The results of the systems biology and MD simulations show that the suggested RNA may be delivered through bioresponsive nanocarriers to speed up wound healing by boosting angiogenesis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13065-023-00969-4.
format Online
Article
Text
id pubmed-10251717
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-102517172023-06-10 In-silico engineering of RNA nanoplatforms to promote the diabetic wound healing Beheshtizadeh, Nima Salimi, Alireza Golmohammadi, Mahsa Ansari, Javad Mohajer Azami, Mahmoud BMC Chem Research One of the most notable required features of wound healing is the enhancement of angiogenesis, which aids in the acceleration of regeneration. Poor angiogenesis during diabetic wound healing is linked to a shortage of pro-angiogenic or an increase in anti-angiogenic factors. As a result, a potential treatment method is to increase angiogenesis promoters and decrease suppressors. Incorporating microRNAs (miRNAs) and small interfering RNAs (siRNAs), two forms of quite small RNA molecules, is one way to make use of RNA interference. Several different types of antagomirs and siRNAs are now in the works to counteract the negative effects of miRNAs. The purpose of this research is to locate novel antagonists for miRNAs and siRNAs that target multiple genes to promote angiogenesis and wound healing in diabetic ulcers. In this context, we used gene ontology analysis by exploring across several datasets. Following data analysis, it was processed using a systems biology approach. The feasibility of incorporating the proposed siRNAs and miRNA antagomirs into polymeric bioresponsive nanocarriers for wound delivery was further investigated by means of a molecular dynamics (MD) simulation study. Among the three nanocarriers tested (Poly (lactic-co-glycolic acid) (PLGA), Polyethylenimine (PEI), and Chitosan (CTS), MD simulations show that the integration of PLGA/hsa-mir-422a is the most stable (total energy = -1202.62 KJ/mol, Gyration radius = 2.154 nm, and solvent-accessible surface area = 408.416 nm(2)). With values of -25.437 KJ/mol, 0.047 nm for the Gyration radius, and 204.563 nm(2) for the SASA, the integration of the second siRNA/ Chitosan took the last place. The results of the systems biology and MD simulations show that the suggested RNA may be delivered through bioresponsive nanocarriers to speed up wound healing by boosting angiogenesis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13065-023-00969-4. Springer International Publishing 2023-06-08 /pmc/articles/PMC10251717/ /pubmed/37291669 http://dx.doi.org/10.1186/s13065-023-00969-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Beheshtizadeh, Nima
Salimi, Alireza
Golmohammadi, Mahsa
Ansari, Javad Mohajer
Azami, Mahmoud
In-silico engineering of RNA nanoplatforms to promote the diabetic wound healing
title In-silico engineering of RNA nanoplatforms to promote the diabetic wound healing
title_full In-silico engineering of RNA nanoplatforms to promote the diabetic wound healing
title_fullStr In-silico engineering of RNA nanoplatforms to promote the diabetic wound healing
title_full_unstemmed In-silico engineering of RNA nanoplatforms to promote the diabetic wound healing
title_short In-silico engineering of RNA nanoplatforms to promote the diabetic wound healing
title_sort in-silico engineering of rna nanoplatforms to promote the diabetic wound healing
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251717/
https://www.ncbi.nlm.nih.gov/pubmed/37291669
http://dx.doi.org/10.1186/s13065-023-00969-4
work_keys_str_mv AT beheshtizadehnima insilicoengineeringofrnananoplatformstopromotethediabeticwoundhealing
AT salimialireza insilicoengineeringofrnananoplatformstopromotethediabeticwoundhealing
AT golmohammadimahsa insilicoengineeringofrnananoplatformstopromotethediabeticwoundhealing
AT ansarijavadmohajer insilicoengineeringofrnananoplatformstopromotethediabeticwoundhealing
AT azamimahmoud insilicoengineeringofrnananoplatformstopromotethediabeticwoundhealing